These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

977 related items for PubMed ID: 29319167

  • 1. Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.
    Nasiri H, Valedkarimi Z, Aghebati-Maleki L, Majidi J.
    J Cell Physiol; 2018 Sep; 233(9):6441-6457. PubMed ID: 29319167
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K, Ito Y.
    Chembiochem; 2019 Nov 04; 20(21):2729-2737. PubMed ID: 30973187
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibody-Drug Conjugates: The New Frontier of Chemotherapy.
    Ponziani S, Di Vittorio G, Pitari G, Cimini AM, Ardini M, Gentile R, Iacobelli S, Sala G, Capone E, Flavell DJ, Ippoliti R, Giansanti F.
    Int J Mol Sci; 2020 Jul 31; 21(15):. PubMed ID: 32752132
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antibody-Drug Conjugates for Cancer Therapy.
    Hafeez U, Parakh S, Gan HK, Scott AM.
    Molecules; 2020 Oct 16; 25(20):. PubMed ID: 33081383
    [Abstract] [Full Text] [Related]

  • 9. Antibody-drug conjugates: Principles and opportunities.
    Phuna ZX, Kumar PA, Haroun E, Dutta D, Lim SH.
    Life Sci; 2024 Jun 15; 347():122676. PubMed ID: 38688384
    [Abstract] [Full Text] [Related]

  • 10. Picking the optimal target for antibody-drug conjugates.
    Mathur R, Weiner GJ.
    Am Soc Clin Oncol Educ Book; 2013 Jun 15. PubMed ID: 23714470
    [Abstract] [Full Text] [Related]

  • 11. Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancement.
    Jiang M, Li Q, Xu B.
    Drug Resist Updat; 2024 Jul 15; 75():101086. PubMed ID: 38677200
    [Abstract] [Full Text] [Related]

  • 12. Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential.
    Ceci C, Lacal PM, Graziani G.
    Pharmacol Ther; 2022 Aug 15; 236():108106. PubMed ID: 34990642
    [Abstract] [Full Text] [Related]

  • 13. Resistance to Antibody-Drug Conjugates.
    García-Alonso S, Ocaña A, Pandiella A.
    Cancer Res; 2018 May 01; 78(9):2159-2165. PubMed ID: 29653942
    [Abstract] [Full Text] [Related]

  • 14. Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates.
    Lu N, Wu J, Tian M, Zhang S, Li Z, Shi L.
    Eur J Med Chem; 2024 Mar 15; 268():116233. PubMed ID: 38408390
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Investigational antibody drug conjugates for solid tumors.
    Sapra P, Hooper AT, O'Donnell CJ, Gerber HP.
    Expert Opin Investig Drugs; 2011 Aug 15; 20(8):1131-49. PubMed ID: 21599617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.
    Vezina HE, Cotreau M, Han TH, Gupta M.
    J Clin Pharmacol; 2017 Oct 15; 57 Suppl 10():S11-S25. PubMed ID: 28921650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.